144 related articles for article (PubMed ID: 6295264)
21. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
[TBL] [Abstract][Full Text] [Related]
22. Comparative in vitro inhibitory and killing activity of cefpirome, ceftazidime, and cefotaxime against Pseudomonas aeruginosa, enterococci, Staphylococcus epidermidis, and methicillin-susceptible and -resistant and tolerant and nontolerant Staphylococcus aureus.
Goldstein EJ; Citron DM
Antimicrob Agents Chemother; 1985 Jul; 28(1):160-2. PubMed ID: 3929677
[TBL] [Abstract][Full Text] [Related]
23. The in-vitro activity of ceftazidime against clinically important pathogens.
Knothe H; Dette GA
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():33-41. PubMed ID: 19810167
[TBL] [Abstract][Full Text] [Related]
24. Comparative in vitro activity of ceftriaxone against clinical bacterial isolates in Nigeria.
Obaseiki-Ebor EE; Afonya TC; Oyaide SM
Chemotherapy; 1985; 31(2):130-7. PubMed ID: 3872779
[TBL] [Abstract][Full Text] [Related]
25. Comparative in vitro activity of cefodizime, ceftazidime, aztreonam, and other selected antimicrobial agents against Neisseria gonorrhoeae.
Khan MY; Gruninger RP; Nelson SM; Obaid SR
Antimicrob Agents Chemother; 1983 Mar; 23(3):477-8. PubMed ID: 6303215
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents.
Rolston KV; Nguyen HT; Ho DH; LeBlanc B; Bodey GP
Antimicrob Agents Chemother; 1992 Apr; 36(4):879-82. PubMed ID: 1503453
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of HRE 664, a penem antibiotic.
Chin XN; Neu HC
Diagn Microbiol Infect Dis; 1990; 13(6):509-16. PubMed ID: 2279381
[TBL] [Abstract][Full Text] [Related]
28. In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Antimicrob Agents Chemother; ; . PubMed ID: 3087274
[TBL] [Abstract][Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
